We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
–
AUM
$4.05B
AUM Growth
+$38.8M
Cap. Flow
-$116M
Cap. Flow %
-2.87%
Top 10 Hldgs %
18.39%
Holding
733
New
60
Increased
226
Reduced
298
Closed
60

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$27.2M
2
AMZN icon
Amazon
AMZN
+$19.4M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$17.8M
4
EAT icon
Brinker International
EAT
+$15.8M
5
APD icon
Air Products & Chemicals
APD
+$15.1M

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$24.7M
2
DIS icon
Walt Disney
DIS
+$19.9M
3
TGT icon
Target
TGT
+$19M
4
DRI icon
Darden Restaurants
DRI
+$18.6M
5
CI icon
Cigna
CI
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.77%
2 Technology 14.35%
3 Financials 11.2%
4 Industrials 10.03%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LXRX icon
501
Lexicon Pharmaceuticals
LXRX
$1.03B
$397K 0.01%
+21,980
New +$354K
DTE icon
502
DTE Energy
DTE
$29.5B
$396K 0.01%
4,971
-353
-7% -$28.8K
PSA icon
503
Public Storage
PSA
$60.4B
$394K 0.01%
1,765
+35
+2% +$8.17K
PPG icon
504
PPG Industries
PPG
$24.7B
$388K 0.01%
3,750
+550
+17% +$57.7K
SI
505
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$385K 0.01%
3,287
+40
+1% +$4.68K
AWK icon
506
American Water Works
AWK
$27B
$378K 0.01%
5,050
– –
BNCL
507
DELISTED
Beneficial Bancorp, Inc.
BNCL
$378K 0.01%
25,675
+1,810
+8% +$25.7K
EBS icon
508
Emergent Biosolutions
EBS
$368M
$377K 0.01%
11,955
+3,495
+41% +$102K
HUM icon
509
Humana
HUM
$44.1B
$375K 0.01%
2,122
-475
-18% -$82.4K
MDT icon
510
Medtronic
MDT
$109B
$372K 0.01%
4,306
-146
-3% -$12.7K
NXPI icon
511
NXP Semiconductors
NXPI
$59.6B
$371K 0.01%
3,640
– –
MKC icon
512
McCormick & Company Non-Voting
MKC
$13.7B
$368K 0.01%
7,372
-17,794
-71% -$902K
ITW icon
513
Illinois Tool Works
ITW
$82.3B
$364K 0.01%
3,040
– –
IWO icon
514
iShares Russell 2000 Growth ETF
IWO
$14.3B
$354K 0.01%
2,380
-241
-9% -$35.1K
MFG icon
515
Mizuho Financial
MFG
$126B
$354K 0.01%
105,498
+500
+0.5% +$1.63K
CAJ
516
DELISTED
Canon, Inc.
CAJ
$352K 0.01%
12,113
+50
+0.4% +$1.43K
VNQI icon
517
Vanguard Global ex-US Real Estate ETF
VNQI
$3.51B
$351K 0.01%
6,240
-253
-4% -$14.1K
DBA icon
518
Invesco DB Agriculture Fund
DBA
$1.23B
$345K 0.01%
17,288
+1,179
+7% +$24.4K
LQD icon
519
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.2B
$337K 0.01%
2,735
– –
TRV icon
520
Travelers Companies
TRV
$79B
$337K 0.01%
2,943
– –
MMP
521
DELISTED
Magellan Midstream Partners, L.P.
MMP
$336K 0.01%
4,750
– –
MDLZ icon
522
Mondelez International
MDLZ
$79.4B
$332K 0.01%
7,557
– –
CHTR icon
523
Charter Communications
CHTR
$17.4B
$329K 0.01%
1,217
-9
-0.7% -$2.27K
PFF icon
524
iShares Preferred and Income Securities ETF
PFF
$13.3B
$328K 0.01%
8,300
+1,020
+14% +$40.7K
CNQ icon
525
Canadian Natural Resources
CNQ
$99.6B
$323K 0.01%
20,616
– –
19 20
21
22 23

Similar funds

GVI
Green Valley Investors Wilmington, Delaware $1.76B AUM 5.64% 1-Year Est. Return
GMI
Greystone Managed Investments Regina, Saskatchewan, Canada $1.65B AUM 7.9% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
AWM
Ashmore Wealth Management Wilmington, Delaware $1.58B AUM 9.28% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Boston Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Boston Advisors held 733 positions worth $4.05B, up 0.97% from $4.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Advisors's Q3 2016 filing shows 60 new, 226 increased, 298 reduced and 60 closed positions. Its largest new stake was Vertex Pharmaceuticals: 188,245 shares worth $16.4M. The largest sale was Clorox, an estimated $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q3 2016 buy was Vertex Pharmaceuticals: 188,245 shares worth $16.4M.
  • Boston Advisors added most to AbbVie in Q3 2016, an estimated $27.2M increase.
  • Boston Advisors's biggest Q3 2016 reduction was Clorox, cutting an estimated $24.7M.
  • Boston Advisors fully exited Cadence Design Systems in Q3 2016, selling an estimated $14.4M.
  • Boston Advisors's ten largest holdings make up 18% of its $4.05B portfolio in Q3 2016.
  • Boston Advisors opened 60 new positions and closed 60 in Q3 2016.
  • Boston Advisors's portfolio value rose 0.97% quarter-over-quarter to $4.05B.

Based on Boston Advisors's 13F filing for Q3 2016, filed 25 Oct 2016.